Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5
Clinical trial NCT03520712 · TERMINATED
Trial details
- NCT number
- NCT03520712
- Sponsor
- BioMarin Pharmaceutical
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-24
- Primary completion
- 2024-08-07
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.